Proton single voxel spectroscopy Ultra high magnetic field of 14.1 T Rat brain LCModel Quantification accuracy a b s t r a c t Ultra-short echo-time proton single voxel spectra of rat brain were obtained on a 14.1 T 26 cm horizontal bore system. At this field, the fitted linewidth in the brain tissue of adult rats was about 11 Hz. New, separated resonances ascribed to phosphocholine, glycerophosphocholine and N-acetylaspartate were detected for the first time in vivo in the spectral range of 4.2-4.4 ppm. Moreover, improved separation of the resonances of lactate, alanine, c-aminobutyrate, glutamate and glutathione was observed. Metabolite concentrations were estimated by fitting in vivo spectra to a linear combination of simulated spectra of individual metabolites and a measured spectrum of macromolecules (LCModel). The calculated concentrations of metabolites were generally in excellent agreement with those obtained at 9.4 T. These initial results further indicated that increasing magnetic field strength to 14.1 T enhanced spectral resolution in 1 H NMR spectroscopy. This implies that the quantification of the neurochemical profile in rodent brain can be achieved with improved accuracy and precision.
Introduction
The ability of in vivo short echo-time 1 H NMR spectroscopy to determine the concentrations of at least 18 metabolites (the neurochemical profile) in rodent brain [1] opens the perspective of studying multiple biomarkers in rodent models of human diseases. Measurements at high magnetic fields are poised to benefit from the higher signal-to-noise ratio (SNR) and increased spectral dispersion, which likely improve quantification accuracy and precision. The benefits are especially expected to be important for metabolites having low concentration or overlapping spectral lines and for compounds giving complex J-coupled spectral patterns. Recent studies, however, have indicated that these advantages may be partially offset by a decrease of T 2 and T Ã 2 with increasing static magnetic field [2, 3] , with some predicting [4] a moderate increase of the signalto-noise ratio (SNR) and a nearly linear increase in the spectral linewidth (expressed in Hz) when increasing B 0 above 9.4 T.
Most high-field short-echo in vivo proton spectroscopy measurements of rodents in the last decade have been performed at 9.4 T. It was shown that a combination of careful eddy current compensation [5] , automatic first-and second-order localized shimming [6] , and an ultra-short echo-time localization technique with efficient water suppression enabled to measure high quality spectra with resolved spectral lines of many metabolites (e.g., the spectrally resolved signals of phosphocreatine and creatine at 3.9 ppm) [7] . The spectral resolution reported in proton spectra of rat brain at 11.7 T [8, 9] appeared consistent with the aforementioned predictions [4] .
Spectra measured at short echo-times are further complicated by broad signals ascribed mainly to cytosolic proteins [10] . At high magnetic fields the largely field-independent linewidth of the signals of macromolecules increasingly approaches that of metabolites and an experimental assessment of macromolecular contribution to the proton spectrum may become crucial for accurate metabolite quantification.
Even at the highest experimentally achievable magnetic field for in vivo experimentation, spectral overlap of proton signals from brain metabolites still may require that concentrations of metabolites are determined by fitting to the measured in vivo data a linear combination of a ''basis set", i.e., the spectra of individual metabolites (obtained either experimentally or using spin simulations [11] ). The most frequently used programs for proton spectra quantification are JMRUI [12] and LCModel [13] working in the time and frequency domain, respectively. Provided such a basis set represents the tissue composition sufficiently well, the fitting routines are expected to be enough robust for the quantification of less abundant metabolites with spectral lines overlapped by dominant resonances. However, concentrations of metabolites, which are poorly characterized in the in vivo proton spectra, can be less accurate and their values can be substantially correlated with the concentrations of dominant metabolites. Thus, we expect that the improved separation of spectral lines at higher magnetic fields results in a more accurate quantification.
With the availability of the first 14.1 T/26 cm MR system we aimed to implement and assess the performance of ultra-short echo-time proton localized spectroscopy of rat brain in vivo and to determine if new spectral features not previously reported at 9.4-11.7 T are present. More specifically, the obtained initial results were compared to the previously suggested field dependence of the spectral linewidth, together with an initial assessment of the reliability and accuracy of the calculated metabolite concentrations.
Methods

Animals
In vivo experiments were performed on the same group of male Sprague-Dawley rats, which were anesthetized with 1.5-2.5% isoflurane using a nose mask. All animal experiments were conducted according to federal and local ethical guidelines and the protocols were approved by the local regulatory body. Body temperature was maintained at 37.5 ± 1.0°C by circulating warm water around the animals.
Instruments and pulse sequences
Proton spectra were measured from the brain of five animals using two MR instruments (Varian, Palo Alto, CA, USA): an INOVA spectrometer interfaced to a 9.4 T, actively shielded magnet with a 31-cm horizontal bore, and an MRI System interfaced to 14.1 T magnet with a 26-cm horizontal bore (both magnets from Magnex Scientific, Oxford, UK). The magnets were equipped with 12-cm inner-diameter actively shielded gradient sets (Magnex Scientific, Oxford, UK) allowing a maximum gradient of 400 mT/m in 120 ls. Home-built quadrature surface coils consisting of two geometrically decoupled 14-mm diameter single loops were used as both transmitter and receiver. The total width of the 9.4 T and 14.1 T RF coils was 18 mm and 21 mm, respectively. Eddy currents were minimized using time dependent quantitative eddy current field mapping [5] . The static field homogeneity was adjusted using first-and second-order shims using an EPI version of FASTMAP [14] .
Localizer images were obtained in the coronal and horizontal planes using a multislice fast spin echo protocol with TE/TR = 60/5000 ms, a slice thickness of 1 mm and an isotropic in-plane resolution of 94 lm. Spectra were obtained by an ultra-short echo-time (TE/TR = 2.8/4000 ms) spin echo full intensity acquired localization (SPECIAL) technique [15] , which combined 1D imageselected in vivo spectroscopy (ISIS) [16] in the vertical (Y) direction with a slice selective spin echo (SE) in the X and Z directions. The acquisition of 4096 complex points followed an add-subtract scheme as in 1D ISIS. Identical RF pulses, gradient amplitudes and sequence timing were used on both instruments. The spectral width was 5 kHz and 7 kHz at 9.4 T and 14.1 T, respectively. In the ISIS part of the sequence, a 2-ms slice selective full-passage hyperbolic secant adiabatic pulse with a bandwidth of 10 kHz was applied in alternate scans. In the SE part of sequence, a 0.5-ms 90°a nd a 1-ms 180°asymmetric slice-selective pulses [7, 17] were used in the directions parallel to the coil plane. The bandwidths of the 90°and 180°pulses were 13.5 kHz and 5.8 kHz, respectively.
VOIs of 50-70 ll were placed laterally to the brain midline and included frontal cortex, corpus callosum and striatum. The voxel position was identical at both field strengths.
Water signal was suppressed by a series of seven 25-ms asymmetric variable power RF pulses (bandwidth = 270 Hz) with optimized relaxation delays (VAPOR) [7] . The water suppression pulses were interleaved with three modules of outer volume saturation using six 1.2-ms full-passage hyperbolic secant band-selective pulses with a bandwidth of 35 kHz. Another frequencyselective saturation pulse (15 ms Gaussian, bandwidth = 180 Hz) was added in the delay between the ISIS and SE modules. For obtaining spectra with comparable SNR at both fields, the number of accumulations was varied from 64 to 160 at 9.4 T and from 16 to 160 at 14.1 T. Data processing included zero-filling up to 16 K data points, Gaussian weighting of the FID, Fourier transformation, and zero-and minimal first-order phase correction. To compensate for the magnetic field drift, spectra were collected in blocks of 16 averages, which were stored separately in the memory and were corrected for the relative shift in frequency.
For estimating the spectrum of macromolecules, the SPECIAL sequence was extended with a 2-ms nonselective full-passage hyperbolic secant inversion pulse (a bandwidth of 10 kHz), which was applied before starting the localization part of the sequence. The repetition time of 2500 ms and the echo time of 2.8 ms or 40 ms were used, the number of accumulations was 640. The macromolecule spectrum was discriminated from signals of metabolites based on a difference in T 1 relaxation times, which are much shorter in macromolecules also at 14.1 T. A series of short echotime (TE = 2.8 ms) inversion recovery spectra were measured with inversion times (TI) of 420, 600, 750, 850 and 1000 ms.
Quantification
Metabolite concentrations were calculated by LCModel using databases of simulated spectra of metabolites combined with spectra of macromolecules measured at both fields. Databases of simulated spectra were created by a home written program in MATLAB (MathWorks, Natick, MA, USA) based on the density matrix formalism [18] , using published values of coupling constants and chemical shifts [11] . The macromolecule spectrum at 14.1 T was measured as a part of this study while the spectrum for the 9.4 T database was taken from the previous study [15] . The spectrum of macromolecules at 14.1 T was processed using the Hankel-Lanczos singular value decomposition (HLSVD) technique [19] implemented in the JMRUI software. In order to assess the importance of the measured spectrum of macromolecules in the quantification of metabolites at 14.1 T, the LCModel analysis of a series of five spectra was repeated twice, with and without including the spectrum of macromolecules in the LCModel database, respectively. In the latter case, LCModel estimated the macromolecular ''baseline" using predefined peaks of macromolecules and lipids and a spline function.
Results
A high magnet stability and the quality of the gradient system were considered important prerequisites for high performance of 1 H NMR spectroscopy. The magnetic field drift on the 14.1 T magnet was less than 0.05 ppm/hour. Eddy currents were minimized to below 0.02%. An increase of approximately 10-20% in SNR values provided by LCModel was observed at 14.1 T in comparison with 9.4 T. The best water and total creatine (CH 3 ) linewidths measured in 5 spectra of adult rats after FASTMAP optimization of first-and second-order shims were about 17 Hz and 14 Hz, respectively. The best values obtained at 9.4 T were about 12.5 Hz and 10.5 Hz for water and creatine signals, respectively. Fig. 1 shows single voxel 9.4 T and 14.1 T spectra of rat brain, measured by the SPECIAL technique, with peak assignments. Two novel prominent features were immediately apparent at 14.1 T, in particular a group of spectral lines resonating between 4.2 and 4.4 ppm, and the narrowing (in ppm) of the spectral lines of GABA, Glu and NAA in the spectral range from 1.8 ppm to 2.6 ppm. In the complex peak at 2.45-2.55 ppm, the glutamate CH 2 protons of GSH (2.56 ppm) were partially resolved from those of NAA (2.49 ppm).
New features of 14.1 T proton spectra
This figure further illustrates increased dispersion at 14.1 T. The improved spectral quality enabled to discern several low-intensity peaks in the spectral region from 3.5 ppm to 4.2 ppm, which were assigned to Lac (at 4.11 ppm), Glc (3.85 ppm) and GPC (3.67 and 3.87 ppm) (Fig. 2, inset) . The resonances in the chemical shift range above 4.2 ppm were detected for the first time in vivo due to the effectively narrower bandwidth used for water suppression, which represents a further manifestation of the increased spatial resolution. They were ascribed to NAA, GPC and PCho at 4.38, 4.31 and 4.27 ppm.
Estimation of the macromolecule spectrum at 14.1 T
The inversion recovery spectra measured with different inversion times are shown in Fig. 2 . Residual peaks of major metabolites were seen in all the spectra due to the high SNR. Since T 1 relaxation times of metabolite resonances were not identical, a macromolecule spectrum with completely nulled metabolite resonances could not be obtained. Thus, the spectrum at TI = 750 ms (Fig. 2c) with the smallest, positive or negative, residual peaks was taken as a basis for the spectrum of macromolecules. Intensity of the residual metabolite peaks in this spectrum was less than 10% of the original signal intensity except for the Cr/PCr peak at 3.9 ppm having substantially shorter T 1 as in previous studies [1] . Identification of these peaks was based on the course of their intensities (changing from negative to positive) over the series of inversion recovery spectra. In addition, the identification was confirmed by measuring an inversion recovery spectrum with TI = 750 ms and TE = 40 ms (Fig. 2f) . In this spectrum the residual signals of metabolites were retained due to longer T 2 relaxation times, while the signals of macromolecules were substantially reduced due to the more rapid signal decay, ascribed to faster T 2 relaxation. In this way, residual peaks of NAA at 2.0 and 2.7 ppm, Tau at 3.4 ppm, total choline at 3.2 ppm, Ins at 3.6 ppm and total Cr at 3.9 ppm were identified. The final macromolecule spectrum after removing residual peaks of metabolites is shown in Fig. 2g . Fig. 3 demonstrates that the spectrum fitted without an experimental macromolecule spectrum was a poorer match of the experimental spectrum, with residuals observed particularly in the spectral region from 0.5 to 2.0 ppm, compared to the LCModel run with the macromolecule spectrum. When omitting the spectrum of macromolecules, the metabolite concentrations of Glc, GABA, PCho, GSH, PE and Asp were higher by about 30-70% whereas the concentrations of Ala, Asc, NAAG and Lac were lower by 70-100% (data not shown).
Determination of metabolite concentrations
The LCModel analysis of a representative 14.1 T spectrum is shown in Fig. 4 . Five spectra having the same SNR (within ±3%) as judged from LCModel outputs at both fields were used to compare mean concentrations, their standard deviations and mean Cramer-Rao lower bounds (CRLB) for 19 metabolites (Table 1) . The concentrations were fitted from the spectral ranges of either 0-4.1 ppm (at 9.4 T and 14.1 T) or 0-4.4 ppm (at 14.1 T only). In general, an excellent agreement between the concentrations obtained at 9.4 and 14.1 T was noted. Substantial differences were observed only for metabolites which are not well characterized at 9.4 T such as Ala, GPC and PCho, GABA, Gly and NAAG.
Discussion
A constant trend towards using higher magnetic fields is seen in high resolution NMR due to the increased SNR and improved resolution. However, the benefits of ultra high fields for in vivo MR spectroscopy may be offset by increases in linewidth due to the heterogeneity of the brain tissue.
Our experiments demonstrated new spectral features at 14.1 T not seen previously at 9.4-11.7 T. For example, the resolved resonances at 4.31 and 4.27 ppm, which typically are saturated at lower fields by water suppression pulses, and additional peaks/peak shoulders of GPC resolved between 3.6 ppm and 3.9 ppm (Fig. 1) may substantially improve the accuracy of the GPC and PCho quantification. The spectra of GPC and PCho at lower magnetic fields show only one common intense resonance line with almost identical chemical shifts, 3.212 ppm and 3.208 ppm, respectively [11] . The other small signals in the range of 3.6-3.9 ppm are obscured by intense signals of Ins, Glu, Gln, Cr and PCr, thus providing very few spectral features that can lead to a robust and separate quantification of GPC and PCho. The concentration of PCho calculated by LCModel at 9.4 T are larger than that of GPC, with calculated standard deviations of about 30%, whereas the concentrations obtained at 14.1 T are reversed and their standard deviations dropped by more than one-half ( Table 1 ). The obtained concentrations of PCho and GPC can in principle be compared with 31 P NMR data, where
PCho and GPC peaks have been resolved. We are aware only of studies on human brain [20] and on brain of newborn piglets [21] showing resolved PCho and GPC peaks. In these 31 P NMR spectra, peak intensities of GPC and PCho agree well with the GPC/PCho ratio found at 14.1 T. The importance of the upfield spectral region for the quantification of PCho and GPC is demonstrated by the LCModel fit at 14.1 T. When only the spectral range from 0 to 4.1 ppm was used (Table 1) , standard deviations dramatically increased and the mean PCho and GPC concentrations changed. These data indicate that the detection of the new spectral lines at 14.1 T improves substantially the precision and likely also accuracy of quantification of GPC and PCho. Similarly, determination of Glc should be improved at 14.1 T since, along with the well-separated peak at 5.23 ppm, there is another spectral line of this compound at 3.85 ppm, which is clearly visible at 14.1 T even at euglycemia. However, the Glc and Lac concentrations could not be reliably compared with those at 9.4 T due to their dependence on animal physiology, such as anesthesia and glycemia. GPC/PCho at 3.2, Ins at 3.6 ppm and Cr/PCr at 3.9 ppm) was considered as a spectrum of macromolecules after removing the residual peaks of metabolites by the HLSVD algorithm (g). The residual signal of NAA at 2.7 ppm marked with asterisk in the spectrum (f) is reduced and inverted relative to that in the spectrum (c) due to J-evolution. Despite excellent spectral dispersion at 14.1 T, many spectral lines of metabolites remained overlapped among each other as well as with macromolecule signals. We demonstrated that an experimental estimation of the macromolecule spectrum representing the ''baseline" of ultra-short echo-time proton spectra can improve the quality of the fit between experimental and simulated spectra at this magnetic field. The absence of the measured macromolecule spectrum in the database led to a large and unpredictable bias in concentrations of many metabolites, in the case of Lac even to the absence of any estimated value.
The estimated spectrum of macromolecule was obtained by a single inversion recovery technique, although this was not the only approach evaluated. The double inversion spectrum reproduced poorly our experimental ''baseline" in the spectral region of 0.5-2 ppm because signal intensities in the macromolecule spectrum obtained by this method were differently T 1 -weighted [4] (data not shown). Due to a relatively high SNR we were able to identify residual peaks of metabolites and remove them from the macromolecule spectrum in the time domain. The LCModel calculations, employing a database of simulated spectra of metabolites combined with the measured spectrum of macromolecules, provided an excellent fit to experimental data (Fig. 4) . Table 1 indicates that relative standard deviations and CRLBs of metabolite concentrations are nearly the same or lower at 14.1 T than at 9.4 T. It should be noted that spectra with the same SNR were compared. Therefore, the observed decrease of standard deviations of Ala, Asp, GABA, Gly and NAAG can be attributed to improved separation of their spectral lines. The removal of residual peaks from the spectrum of macromolecules at 14.1 T could further improve accuracy of quantification of some metabolites having their spectral lines co-registered with the residual peaks, namely Gly, Asp and PCho. Thus, the concentrations of several poorly represented metabolites are expected to be more accurate at 14.1 T. Specifically, the Ala concentration of 0.6 mmol/kg found at 14.1 T is close to the value of about 0.65 mmol/kg found by ex vivo 1 H NMR in the rat cortex [22] . The concentration of GABA measured at 14.1 T is similar to the concentration of 1.8 mmol/kg found in the whole rat brain and to the average value of 1.25 and 2.21 mmol/kg found in rat cortex and striatum, respectively, by enzymatic-fluorometric analysis of brain extracts [23] . The LCModel estimate at 14.1 T for the Gly concentration was in excellent agreement with the value of 1.0 mmol/kg determined by high performance liquid chromatography in brain extracts [24] and by in vivo spectroscopy of rat brain at a longer echo time [25] . For comparing uncertainties of metabolite concentrations at both fields we used two parameters: standard deviations, which contain also inter-animal variations, and CRLBs. The CRLBs are estimates of standard deviations of concentrations in individual spectra, however, they assume that the model is correct or at least sufficiently parameterized to describe the data (S. Provencher, LCModel & LCMgui User's Manual, http://s-provencher.com/ pages/lcmodel.shtml). Thus, comparison of CRLBs for PCho, GPC, Lac and NAA using different models, with and without spectral lines in the 4.1-4.4 ppm region, might not be fully adequate.
The smaller than the theoretically predicted 50% increase in sensitivity can be in part explained by small differences in hardware of both scanners. The width of the RF coil at 14.1 T was slightly larger than the width of the coil used at 9.4 T, which was estimated to account for a 25% decrease in signal intensity at 14.1 T. Another 10% signal attenuation was due to cable insertion losses at 14.1 T, which can be minimized by moving the preamplifier closer to the RF coil. Taking these differences in hardware into account, the observed increase in SNR at 14.1 T was consistent with theoretical expectations of $50%.
The width of water and Cr lines at 14.1 T were larger than the values obtained at 9.4 T by a factor of about 1.35, which was Table 1 , Mac is the macromolecule spectrum. The spectra in each pair had the same SNR (within ±3%), the overall range of SNR was 27-40. a Metabolite concentrations, which were found significantly different at 14.1 T compared to 9.4 T (t < 0.1). b Only the spectral range from 0 to 4.1 ppm was used in the LCModel fit.
slightly, but markedly less than predicted by de Graaf et al. [4] . The linewidth in the 14.1 T spectra, as fitted by LCModel, was about 11 Hz, which is much smaller than the value of about 14 Hz obtained experimentally on the methyl signal of total Cr at 3.03 ppm. However, the linewidth of the Cr signal comprises not only the natural linewidth but also the difference of 0. 
